Trial Profile
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms TOPLEVEL
- 24 Aug 2020 Planned End Date changed to 30 Jun 2022.
- 24 Aug 2020 Status changed from recruiting to active, no longer recruiting.
- 20 Aug 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.